Brokerages Set HealthEquity, Inc. (NASDAQ:HQY) Target Price at $103.83

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been assigned an average rating of “Buy” from the twelve analysts that are presently covering the firm, Marketbeat.com reports. Twelve equities research analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $103.83.

HQY has been the subject of several recent analyst reports. JMP Securities restated a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. Bank of America lowered their price objective on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, September 4th. Barrington Research reissued an “outperform” rating and set a $105.00 price target on shares of HealthEquity in a research report on Friday, September 20th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a report on Wednesday, September 4th.

HealthEquity Stock Performance

Shares of HQY stock opened at $87.57 on Tuesday. HealthEquity has a 52 week low of $61.81 and a 52 week high of $89.23. The stock has a market capitalization of $7.62 billion, a PE ratio of 95.18, a P/E/G ratio of 1.31 and a beta of 0.52. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm has a 50 day moving average of $80.05 and a two-hundred day moving average of $79.68.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. On average, research analysts predict that HealthEquity will post 2.27 EPS for the current fiscal year.

Insider Activity at HealthEquity

In other news, Director Frank Corvino sold 1,247 shares of HealthEquity stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total value of $100,084.22. Following the transaction, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the sale, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Frank Corvino sold 1,247 shares of the business’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares of the company’s stock, valued at approximately $387,093.98. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On HealthEquity

A number of institutional investors have recently made changes to their positions in the stock. International Assets Investment Management LLC bought a new position in HealthEquity in the second quarter valued at $35,000. Paladin Wealth LLC bought a new position in shares of HealthEquity during the third quarter worth approximately $39,000. Fidelis Capital Partners LLC acquired a new position in HealthEquity in the 1st quarter valued at $42,000. GAMMA Investing LLC lifted its position in HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock worth $51,000 after purchasing an additional 318 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of HealthEquity during the 2nd quarter worth approximately $73,000. 99.55% of the stock is owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.